Author

R. Baric

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2 Microbiology· 2 Biochemistry· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 4 Approach:experimental assay· 4 Organism:mouse· 3 Research Focus:cell type annotation· 2 Organism:non-human primate· 2 Assay:CITE-seq· 1 Approach:genetic perturbation / CRISPR· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

A. Schaefer· 3 shared A. M. DeSilva· 2 shared L. J. White· 2 shared L. V. Tse· 2 shared N. P. King· 2 shared R. M. Meganck· 2 shared S. Dong· 2 shared A. Blackstone· 1 shared

Activity by Year

2021-2023 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 17 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

A. Schaefer

Mutual co-authors in cluster

Author profile →

5 papers

Recent·Most cited

A broadly generalizable stabilization strategy for sarbecovirus fusion machinery vaccines

J. Lee, C. Stewart, A. Schaefer, E. M. Leaf, Y.-J. Park, D. Asarnow, J. M. Powers, C. Treichel, D. Corti, R. Baric, N. P. King, D. Veesler

This paper develops a stabilization strategy for sarbecovirus fusion machinery vaccines, showing broad reactivity and protection against SARS-CoV-2 variants.

bioRxiv · Dec 12, 2023Biochemistry

Evolution of a Functionally Intact but Antigenically Distinct DENV Fusion Loop

R. M. Meganck, D. Zhu, S. Dong, L. J. Snoderly-Foster, Y. R. Dalben, D. J. Thiono, L. J. White, A. M. DeSilva, R. Baric, L. V. Tse

This study engineers DENV variants with mutated fusion loops that evade neutralizing antibodies but retain sensitivity to cross-reactive antibodies, offering tools for vaccine development.

bioRxiv · Mar 22, 2023 · PreprintMicrobiology

Engineered Immunogens to Elicit Antibodies Against Conserved Coronavirus Epitopes

B. Kapingidza, D. J. Marston, C. Harris, D. Wrapp, K. Winters, D. Mielke, L. Xiaozhi, Q. Yin, A. Foulger, R. Parks, M. Barr, A. Newman, A. Schaefer, A. Eaton, J. M. Flores, , M. L. Azoitei

This study designs engineered immunogens targeting conserved coronavirus epitopes to elicit broad-spectrum antibodies, showing protection in mice against live virus challenge.

bioRxiv · Feb 27, 2023Immunology

Genetically Engineered DENV Produces Antigenically Distinct Mature Particles

L. V. Tse, R. M. Meganck, S. Dong, L. E. Adams, L. J. White, A. M. deSilva, R. Baric

This study genetically engineers DENV to produce antigenically distinct mature particles, offering new tools for vaccine development and maturation studies.

bioRxiv · Apr 6, 2021 · PreprintMicrobiology

Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines

A. C. Walls, M. C. Miranda, M. N. Pham, A. Schaefer, A. Greaney, P. S. Arunachalam, M.-J. Navarro, M. A. Tortorici, K. Rogers, M. A. O'Connor, L. Shireff, D. E. Ferrell, N. Brunette, E. Kepl, J. E. Bowen, , Veesler

This study shows that a SARS-CoV-2 RBD nanoparticle vaccine protects against SARS-CoV-2 and related sarbecoviruses, including variants, in mice and non-human primates.

bioRxiv · Mar 15, 2021Immunology